ST
ACHN

Spot Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

Spot Trading’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,836
Closed -$39K – 3368
2016
Q3 		$39K Buy
+4,836
New +$41.1K ﹤0.01% 2677
2016
Q1 		– Sell
-11
Closed – – 4231
2015
Q4 		$0 Sell
11
-23,271
-100% -$212K ﹤0.01% 4262
2015
Q3 		$161K Buy
+23,282
New +$190K ﹤0.01% 2818
2015
Q1 		– Sell
-854
Closed -$10K – 4502
2014
Q4 		$10K Sell
854
-33,518
-98% -$409K ﹤0.01% 3693
2014
Q3 		$343K Buy
+34,372
New +$319K ﹤0.01% 2822
2014
Q1 		– Sell
-41,721
Closed -$138K – 4649
2013
Q4 		$138K Sell
41,721
-16,129
-28% -$46.8K ﹤0.01% 3184
2013
Q3 		$175K Buy
+57,850
New +$397K ﹤0.01% 3107

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Spot Trading's ACHN Position: Q4 2016 in Review

Spot Trading sold out of Achillion Pharmaceuticals (ACHN) in Q4 2016, closing a stake of 4,836 shares — an estimated $39K sold.

Spot Trading first reported a position in ACHN in Q3 2013 and held it in 7 quarters. The position peaked at $343K in Q3 2014. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

  • Spot Trading reported no remaining Achillion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 4,836 Achillion Pharmaceuticals shares in Q4 2016, an estimated $39K.
  • Spot Trading first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Spot Trading's Achillion Pharmaceuticals position peaked at $343K in Q3 2014.
  • 140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.